{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:04:01Z","timestamp":1790147041999,"version":"4.0.1"},"reference-count":177,"publisher":"Bentham Science Publishers Ltd.","issue":"3","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRCEP"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Treatment-Resistant Depression (TRD) is a complex clinical condition characterized\nby inadequate response to conventional antidepressant treatments. There is growing evidence that\nmicroRNAs (miRNAs) play a role in the underlying pathophysiology of TRD and may offer new avenues\nfor diagnostics and therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A structured literature review of peer-reviewed publications indexed in PubMed, Scopus, and\nWeb of Science was conducted. The search strategy included combinations of keywords such as \u201ctreatment-\nresistant depression,\u201d \u201cmicroRNAs,\u201d \u201cbiomarkers,\u201d and \u201cmiRNA-based interventions.\u201d Articles\nwere selected based on relevance to miRNA expression patterns in TRD, therapeutic modulation, and\ntheir clinical potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Dysregulation of several miRNAs\u2014including miR-135a, miR-34a, and miR-155\u2014was consistently\nobserved in patients with TRD. These miRNAs were linked to impaired synaptic plasticity and persistent\nneuroinflammation. Therapeutic approaches using miRNA mimics or inhibitors showed potential\nin restoring neurobiological balance and enhancing response to traditional antidepressants. However, delivery\nsystem limitations and blood-brain barrier penetration remain significant challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>miRNAs appear to play a dual role in TRD, serving both as biomarkers for diagnosis and as\ntargets for novel therapies. Integrating miRNA profiling into clinical workflows could enhance diagnostic\nprecision and guide individualized treatment strategies. Translational barriers, such as delivery specificity\nand standardization of detection protocols, must be addressed before the widespread clinical application\nof this technology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This review highlights miRNAs as promising diagnostic and therapeutic tools in TRD. Continued\nadvancements in delivery systems and validation of biomarker panels may pave the way for their\nclinical implementation in personalized psychiatry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0127724328381443250825092900","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:36:57Z","timestamp":1756964217000},"page":"171-200","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MicroRNAs as Biomarkers and Therapeutic Targets in Treatment- Resistant Depression: Unveiling Diagnostic and Treatment Pathways"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9519-6338","authenticated-orcid":true,"given":"Alaa A. A.","family":"Aljabali","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, Yarmouk University, Irbid 21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almuthanna K.","family":"Alkaraki","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Faculty of Science, Yarmouk University, Irbid 21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Gammoh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, PO BOX 566, Irbid, 21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esam","family":"Qnais","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahim","family":"Alqudah","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walhan","family":"Alshaer","sequence":"additional","affiliation":[{"name":"Cell Therapy Center, University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Mishra","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara (Punjab) 144411, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachana","family":"Mishra","sequence":"additional","affiliation":[{"name":"School of Bioengineering and Biosciences, Lovely Professional University, Phagwara (Punjab) 144411, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Tanani","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s40273-021-01040-7","volume":"39","author":"Proudman D.","year":"2021","unstructured":"Proudman D.; Greenberg P.; Nellesen D.; The growing burden of major depressive disorders (MDD): implications for researchers and policy makers. PharmacoEconomics  2021,39(6),619-25","journal-title":"PharmacoEconomics"},{"key":"ref=2","unstructured":"The World Health Report 2001: Mental health: new understanding, new hope. World Health Organization 2001","journal-title":"World Health Organization 2001"},{"key":"ref=3","year":"2006","unstructured":"Neurological disorders: public health challenges. World Health Organization 2006"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","volume":"9","author":"Marx W.","year":"2023","unstructured":"Marx W.; Penninx B.W.J.H.; Solmi M.; Major depressive disorder. Nat Rev Dis Primers  2023,9(1),44","journal-title":"Nat Rev Dis Primers"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1590\/1516-4446-2020-0650","volume":"42","author":"Guti\u00e9rrez-Rojas L.","year":"2020","unstructured":"Guti\u00e9rrez-Rojas L.; Porras-Segovia A.; Dunne H.; Andrade-Gonz\u00e1lez N.; Cervilla J.A.; Prevalence and correlates of major depressive disorder: A systematic review. Br J Psychiatry  2020,42(6),657-72","journal-title":"Br J Psychiatry"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/PPA.S29716","volume":"6","author":"Al-harbi K.S.","year":"2012","unstructured":"Al-harbi K.S.; Treatment-resistant depression: Therapeutic trends, challenges, and future directions. Patient Prefer Adherence  2012,6,369-88","journal-title":"Patient Prefer Adherence"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/wps.21120","volume":"22","author":"McIntyre R.S.","year":"2023","unstructured":"McIntyre R.S.; Alsuwaidan M.; Baune B.T.; Treatment\u2010resistant depression: Definition, prevalence, detection, management, and investigational interventions. World Psychiatry  2023,22(3),394-412","journal-title":"World Psychiatry"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"100205","DOI":"10.1016\/j.psycr.2024.100205","volume":"3","author":"Voytenko V.L.","year":"2024","unstructured":"Voytenko V.L.; Street P.; VanOrman B.T.; Psychiatric comorbidities in treatment-resistant depression: Insights from a second-opinion consultation case series. Psychiatry Res Case Rep  2024,3(1),100205","journal-title":"Psychiatry Res Case Rep"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e729","DOI":"10.1016\/S2468-2667(21)00047-5","volume":"6","author":"Arias-de la Torre J.","year":"2021","unstructured":"Arias-de la Torre J.; Vilagut G.; Ronaldson A.; Prevalence and variability of current depressive disorder in 27 European countries: A population-based study. Lancet Public Health  2021,6(10),e729-38","journal-title":"Lancet Public Health"},{"key":"ref=10","year":"2017","unstructured":"Depression and other common mental disorders: global health estimates. World Health OrganiZation 2017"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1038\/s41598-018-21243-x","volume":"8","author":"Lim G.Y.","year":"2018","unstructured":"Lim G.Y.; Tam W.W.; Lu Y.; Ho C.S.; Zhang M.W.; Ho R.C.; Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep  2018,8(1),2861","journal-title":"Sci Rep"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"Nemeth K.","year":"2024","unstructured":"Nemeth K.; Bayraktar R.; Ferracin M.; Calin G.A.; Non-coding RNAs in disease: From mechanisms to therapeutics. Nat Rev Genet  2024,25(3),211-32","journal-title":"Nat Rev Genet"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrg2083","volume":"8","author":"Kapranov P.","year":"2007","unstructured":"Kapranov P.; Willingham A.T.; Gingeras T.R.; Genome-wide transcription and the implications for genomic organization. Nat Rev Genet  2007,8(6),413-23","journal-title":"Nat Rev Genet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"Kozomara A.","year":"2019","unstructured":"Kozomara A.; Birgaoanu M.; Griffiths-Jones S.; miRBase: from microRNA sequences to function. Nucleic Acids Res  2019,47(D1),D155-62","journal-title":"Nucleic Acids Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"Lewis B.P.","year":"2005","unstructured":"Lewis B.P.; Burge C.B.; Bartel D.P.; Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell  2005,120,15-20","journal-title":"Cell"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","volume":"24","author":"Shang R.","year":"2023","unstructured":"Shang R.; Lee S.; Senavirathne G.; Lai E.C.; microRNAs in action: Biogenesis, function and regulation. Nat Rev Genet  2023,24(12),816-33","journal-title":"Nat Rev Genet"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/genes14020314","volume":"14","author":"Iacomino G.","year":"2023","unstructured":"Iacomino G.; miRNAs: The road from bench to bedside. Genes  2023,14(2),314","journal-title":"Genes"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s12276-020-0418-9","volume":"52","author":"Park S.A.","year":"2020","unstructured":"Park S.A.; Han S.M.; Kim C.E.; New fluid biomarkers tracking non-amyloid-\u03b2 and non-tau pathology in Alzheimer\u2019s disease. Exp Mol Med  2020,52(4),556-68","journal-title":"Exp Mol Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/s41380-021-01062-9","volume":"26","author":"Fabbri C.","year":"2021","unstructured":"Fabbri C.; Hagenaars S.P.; John C.; Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts. Mol Psychiatry  2021,26(7),3363-73","journal-title":"Mol Psychiatry"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s43440-023-00542-9","volume":"75","author":"Kolasa M.","year":"2023","unstructured":"Kolasa M.; Faron-G\u00f3recka A.; Preclinical models of treatment-resistant depression: Challenges and perspectives. Pharmacol Rep  2023,75(6),1326-40","journal-title":"Pharmacol Rep"},{"key":"ref=21","year":"2022","unstructured":"Depression in adults: treatment and management. Nice UK 2022"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"o1557","DOI":"10.1136\/bmj.o1557","volume":"378","author":"Kendrick T.","year":"2022","unstructured":"Kendrick T.; Pilling S.; Mavranezouli I.; Management of depression in adults: Summary of updated NICE guidance. BMJ  2022,378,o1557","journal-title":"BMJ"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"e073823","DOI":"10.1136\/bmj-2022-073823","volume":"386","author":"Njenga C.","year":"2024","unstructured":"Njenga C.; Ramanuj P.P.; de Magalh\u00e3es F.J.C.; Pincus H.A.; New and emerging treatments for major depressive disorder. BMJ  2024,386,e073823","journal-title":"BMJ"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12991-023-00478-7","volume":"22","author":"Maina G.","year":"2023","unstructured":"Maina G.; Adami M.; Ascione G.; Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel. Ann Gen Psychiatry  2023,22(1),48","journal-title":"Ann Gen Psychiatry"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jad.2021.12.134","volume":"302","author":"Nu\u00f1ez N.A.","year":"2022","unstructured":"Nu\u00f1ez N.A.; Joseph B.; Pahwa M.; Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis. J Affect Disord  2022,302,385-400","journal-title":"J Affect Disord"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrfmmm.2011.03.009","volume":"717","author":"Almeida M.I.","year":"2011","unstructured":"Almeida M.I.; Reis R.M.; Calin G.A.; MicroRNA history: Discovery, recent applications, and next frontiers. Mutat Res  2011,717(1-2),1-8","journal-title":"Mutat Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","volume":"20","author":"Treiber T.","year":"2019","unstructured":"Treiber T.; Treiber N.; Meister G.; Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol  2019,20(1),5-20","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1007\/s12035-022-02907-2","volume":"59","author":"Mohammadi A.H.","year":"2022","unstructured":"Mohammadi A.H.; Seyedmoalemi S.; Moghanlou M.; MicroRNAs and synaptic plasticity: From their molecular roles to response to therapy. Mol Neurobiol  2022,59(8),5084-102","journal-title":"Mol Neurobiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/1073858417721150","volume":"24","author":"Gaudet A.D.","year":"2018","unstructured":"Gaudet A.D.; Fonken L.K.; Watkins L.R.; Nelson R.J.; Popovich P.G.; MicroRNAs: Roles in regulating neuroinflammation. Neuroscientist  2018,24(3),221-45","journal-title":"Neuroscientist"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10238-024-01334-y","volume":"24","author":"Nalbant E.","year":"2024","unstructured":"Nalbant E.; Akkaya-Ulum Y.Z.; Exploring regulatory mechanisms on miRNAs and their implications in inflammation-related diseases. Clin Exp Med  2024,24(1),142","journal-title":"Clin Exp Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"104369","DOI":"10.1016\/j.envexpbot.2020.104369","volume":"184","author":"Pagano L.","year":"2021","unstructured":"Pagano L.; Rossi R.; Paesano L.; Marmiroli N.; Marmiroli M.; miRNA regulation and stress adaptation in plants. Environ Exp Bot  2021,184,104369","journal-title":"Environ Exp Bot"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"jcs202002","DOI":"10.1242\/jcs.202002","volume":"131","author":"Kucherenko M.M.","year":"2018","unstructured":"Kucherenko M.M.; Shcherbata H.R.; miRNA targeting and alternative splicing in the stress response \u2013 events hosted by membrane-less compartments. J Cell Sci  2018,131(4),jcs202002","journal-title":"J Cell Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00018-017-2591-0","volume":"75","author":"Olejniczak M.","year":"2018","unstructured":"Olejniczak M.; Kotowska-Zimmer A.; Krzyzosiak W.; Stress-induced changes in miRNA biogenesis and functioning. Cell Mol Life Sci  2018,75(2),177-91","journal-title":"Cell Mol Life Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.3390\/cells11152332","volume":"11","author":"Holjencin C.","year":"2022","unstructured":"Holjencin C.; Jakymiw A.; MicroRNAs and their big therapeutic impacts: delivery strategies for cancer intervention. Cells  2022,11(15),2332","journal-title":"Cells"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1002\/mog2.93","volume":"3","author":"Wang Z.","year":"2024","unstructured":"Wang Z.; Wang H.; Zhou S.; Mao J.; Zhan Z.; Duan S.; miRNA interplay: Mechanisms and therapeutic interventions in cancer. MedComm Oncol  2024,3(4),e93","journal-title":"MedComm Oncol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/mps4010010","volume":"4","author":"Dasgupta I.","year":"2021","unstructured":"Dasgupta I.; Chatterjee A.; Recent advances in miRNA delivery systems. Methods Protoc  2021,4(1),10","journal-title":"Methods Protoc"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s11920-024-01494-4","volume":"26","author":"Havlik J.L.","year":"2024","unstructured":"Havlik J.L.; Wahid S.; Teopiz K.M.; McIntyre R.S.; Krystal J.H.; Rhee T.G.; Recent advances in the treatment of treatment-resistant depression: A narrative review of literature published from 2018 to 2023. Curr Psychiatry Rep  2024,26(4),176-213","journal-title":"Curr Psychiatry Rep"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1176\/appi.ajp.20230025","volume":"180","author":"Jha M.K.","year":"2023","unstructured":"Jha M.K.; Mathew S.J.; Pharmacotherapies for treatment-resistant depression: How antipsychotics fit in the rapidly evolving therapeutic landscape. Am J Psychiatry  2023,180(3),190-9","journal-title":"Am J Psychiatry"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41386-022-01370-w","volume":"48","author":"Appelbaum L.G.","year":"2023","unstructured":"Appelbaum L.G.; Shenasa M.A.; Stolz L.; Daskalakis Z.; Synaptic plasticity and mental health: Methods, challenges and opportunities. Neuropsychopharmacology  2023,48(1),113-20","journal-title":"Neuropsychopharmacology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41539-019-0048-y","volume":"4","author":"Abraham W.C.","year":"2019","unstructured":"Abraham W.C.; Jones O.D.; Glanzman D.L.; Is plasticity of synapses the mechanism of long-term memory storage? NPJ Sci Learning  2019,4(1),9","journal-title":"NPJ Sci Learning"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/ijms20071546","volume":"20","author":"Sessa F.","year":"2019","unstructured":"Sessa F.; Maglietta F.; Bertozzi G.; Human brain injury and mirnas: An experimental study. Int J Mol Sci  2019,20(7),1546","journal-title":"Int J Mol Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/cns.12142","volume":"19","author":"Sun Y.","year":"2013","unstructured":"Sun Y.; Gui H.; Li Q.; MicroRNA-124 protects neurons against apoptosis in cerebral ischemic stroke. CNS Neurosci Ther  2013,19(10),813-9","journal-title":"CNS Neurosci Ther"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.1038\/srep06718","volume":"4","author":"Ge X.T.","year":"2014","unstructured":"Ge X.T.; Lei P.; Wang H.C.; miR-21 improves the neurological outcome after traumatic brain injury in rats. Sci Rep  2014,4(1),6718","journal-title":"Sci Rep"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3389\/fphar.2017.00770","volume":"8","author":"Qian Y.","year":"2017","unstructured":"Qian Y.; Song J.; Ouyang Y.; Advances in roles of miR-132 in the nervous system. Front Pharmacol  2017,8,770","journal-title":"Front Pharmacol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fnmol.2020.00090","volume":"13","author":"Fan W.","year":"2020","unstructured":"Fan W.; Liang C.; Ou M.; MicroRNA-146a is a wide-reaching neuroinflammatory regulator and potential treatment target in neurological diseases. Front Mol Neurosci  2020,13,90","journal-title":"Front Mol Neurosci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"111198","DOI":"10.1016\/j.biopha.2020.111198","volume":"135","author":"Ghafouri-Fard S.","year":"2021","unstructured":"Ghafouri-Fard S.; Shoorei H.; Bahroudi Z.; Abak A.; Majidpoor J.; Taheri M.; An update on the role of miR-124 in the pathogenesis of human disorders. Biomed Pharmacother  2021,135,111198","journal-title":"Biomed Pharmacother"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/jnc.12731","volume":"130","author":"Jadhav S.P.","year":"2014","unstructured":"Jadhav S.P.; Kamath S.P.; Choolani M.; Lu J.; Dheen S.T.; microRNA\u2010200b modulates microglia\u2010mediated neuroinflammation via the cJun\/MAPK pathway. J Neurochem  2014,130(3),388-401","journal-title":"J Neurochem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"C3","DOI":"10.1152\/ajpcell.00022.2019","volume":"317","author":"Ma Q.","year":"2019","unstructured":"Ma Q.; Zhang L.; Pearce W.J.; MicroRNAs in brain development and cerebrovascular pathophysiology. Am J Physiol Cell Physiol  2019,317(1),C3-C19","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.3390\/ijms23094555","volume":"23","author":"Gao Y.N.","year":"2022","unstructured":"Gao Y.N.; Zhang Y.Q.; Wang H.; Deng Y.L.; Li N.M.; A new player in depression: MiRNAs as modulators of altered synaptic plasticity. Int J Mol Sci  2022,23(9),4555","journal-title":"Int J Mol Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1113\/JP283719","volume":"601","author":"Morris G.","year":"2023","unstructured":"Morris G.; MicroRNAs \u2013 small RNAs with a big influence on brain excitability. J Physiol  2023,601(10),1711-8","journal-title":"J Physiol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s11033-024-09554-x","volume":"51","author":"Cai L.","year":"2024","unstructured":"Cai L.; Xu J.; Liu J.; miRNAs in treatment-resistant depression: A systematic review. Mol Biol Rep  2024,51(1),638","journal-title":"Mol Biol Rep"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40246-021-00354-z","volume":"15","author":"Li L.D.","year":"2021","unstructured":"Li L.D.; Naveed M.; Du Z.W.; Abnormal expression profile of plasma-derived exosomal microRNAs in patients with treatment-resistant depression. Hum Genomics  2021,15(1),55","journal-title":"Hum Genomics"},{"key":"ref=53","first-page":"493","author":"Costa A.P.","year":"2022","unstructured":"Costa A.P.; Machado-Vieira R.; Kaster M.P.; Drugs under investigation for treatment-resistant depression. In: Managing Treatment-Resistant Depression  2022,493-503","journal-title":"In: Managing Treatment-Resistant Depression"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00109-021-02052-8","volume":"99","author":"Miao C.","year":"2021","unstructured":"Miao C.; Chang J.; The important roles of microRNAs in depression: New research progress and future prospects. J Mol Med (Berl)  2021,99(5),619-36","journal-title":"J Mol Med (Berl)"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3892\/etm.2022.11552","volume":"24","author":"Li Y.","year":"2022","unstructured":"Li Y.; Tan S.; Shen Y.; Guo L.; miR-146a-5p negatively regulates the IL-1\u03b2-stimulated inflammatory response via downregulation of the IRAK1\/TRAF6 signaling pathway in human intestinal epithelial cells. Exp Ther Med  2022,24(4),615","journal-title":"Exp Ther Med"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41435-019-0084-x","volume":"21","author":"Lyu B.","year":"2020","unstructured":"Lyu B.; Wei Z.; Jiang L.; Ma C.; Yang G.; Han S.; MicroRNA-146a negatively regulates IL-33 in activated group 2 innate lymphoid cells by inhibiting IRAK1 and TRAF6. Genes Immun  2020,21(1),37-44","journal-title":"Genes Immun"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e101530","DOI":"10.1371\/journal.pone.0101530","volume":"9","author":"Jiang W.","year":"2014","unstructured":"Jiang W.; Kong L.; Ni Q.; miR-146a ameliorates liver ischemia\/reperfusion injury by suppressing IRAK1 and TRAF6. PLoS One  2014,9(7),e101530","journal-title":"PLoS One"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1074\/jbc.M114.591420","volume":"290","author":"Park H.","year":"2015","unstructured":"Park H.; Huang X.; Lu C.; Cairo M.S.; Zhou X.; MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins. J Biol Chem  2015,290(5),2831-41","journal-title":"J Biol Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"105040","DOI":"10.1016\/j.neubiorev.2023.105040","volume":"146","author":"Roy B.","year":"2023","unstructured":"Roy B.; Dwivedi Y.; An insight into the sprawling microverse of microRNAs in depression pathophysiology and treatment response. Neurosci Biobehav Rev  2023,146,105040","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/jpm11030167","volume":"11","author":"Czarny P.","year":"2021","unstructured":"Czarny P.; Bia\u0142ek K.; Zi\u00f3\u0142kowska S.; Strycharz J.; Barszczewska G.; Sliwinski T.; The importance of epigenetics in diagnostics and treatment of major depressive disorder. J Pers Med  2021,11(3),167","journal-title":"J Pers Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-031-32035-4_34-1","author":"Karacicek B.","year":"2024","unstructured":"Karacicek B.; Ceylan D.; \u00c7elik H.E.A.; Genc S.; Extracellular vesicles in depression. In: Handbook of the Biology and Pathology of Mental Disorders  2024,1-24","journal-title":"In: Handbook of the Biology and Pathology of Mental Disorders"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.3390\/ijms24054664","volume":"24","author":"Roy B.","year":"2023","unstructured":"Roy B.; Ochi S.; Dwivedi Y.; Potential of circulating miRNAs as molecular markers in mood disorders and associated suicidal behavior. Int J Mol Sci  2023,24(5),4664","journal-title":"Int J Mol Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2174\/1875692115666170403101207","volume":"14","author":"Kaur U.","year":"2017","unstructured":"Kaur U.; Chakrabarti S.S.; Gambhir I.; Newer insights in personalized and evidence based medicine- the role of MicroRNAs. Curr Pharmacogenomics Person Med   [Formerly Current Pharmacogenomics].2017,14(2),106-23","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/B978-0-12-823931-5.00010-4","author":"Mondal P.","year":"2023","unstructured":"Mondal P.; Sarkar S.; Das A.; Epigenetic regulations in neurological disorders. In: Epigenetics in Organ Specific Disorders  2023,269-310","journal-title":"In: Epigenetics in Organ Specific Disorders"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/scan\/nsaa159","volume":"16","author":"Hermann A.","year":"2021","unstructured":"Hermann A.; Neudert M.K.; Sch\u00e4fer A.; Lasting effects of cognitive emotion regulation: Neural correlates of reinterpretation and distancing. Soc Cogn Affect Neurosci  2021,16(3),268-79","journal-title":"Soc Cogn Affect Neurosci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"569","DOI":"10.20892\/j.issn.2095-3941.2020.0033","volume":"17","author":"Cao Z.","year":"2020","unstructured":"Cao Z.; Qiu J.; Yang G.; MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy. Cancer Biol Med  2020,17(3),569-82","journal-title":"Cancer Biol Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.imlet.2020.07.008","volume":"227","author":"Mortazavi-Jahromi S.S.","year":"2020","unstructured":"Mortazavi-Jahromi S.S.; Aslani M.; Mirshafiey A.; A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases. Immunol Lett  2020,227,8-27","journal-title":"Immunol Lett"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1038\/s41388-023-02801-8","volume":"42","author":"Abdelaal A.M.","year":"2023","unstructured":"Abdelaal A.M.; Sohal I.S.; Iyer S.; A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy. Oncogene  2023,42(40),2985-99","journal-title":"Oncogene"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s10571-021-01091-6","volume":"42","author":"Xu J.","year":"2022","unstructured":"Xu J.; Zheng Y.; Wang L.; miR-124: A promising therapeutic target for central nervous system injuries and diseases. Cell Mol Neurobiol  2022,42(7),2031-53","journal-title":"Cell Mol Neurobiol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ncrna3030022","volume":"3","author":"Testa U.","year":"2017","unstructured":"Testa U.; Pelosi E.; Castelli G.; Labbaye C.; miR-146 and miR-155: Two key modulators of immune response and tumor development. Noncoding RNA  2017,3(3),22","journal-title":"Noncoding RNA"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13148-017-0413-8","volume":"9","author":"Sandoval-B\u00f3rquez A.","year":"2017","unstructured":"Sandoval-B\u00f3rquez A.; Polakovicova I.; Carrasco-V\u00e9liz N.; MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer. Clin Epigenetics  2017,9(1),114","journal-title":"Clin Epigenetics"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"e70121","DOI":"10.1111\/jcmm.70121","volume":"28","author":"Ardinal A.P.","year":"2024","unstructured":"Ardinal A.P.; Wiyono A.V.; Estiko R.I.; Unveiling the therapeutic potential of miR \u2010146a: Targeting innate inflammation in atherosclerosis. J Cell Mol Med  2024,28(19),e70121","journal-title":"J Cell Mol Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3892\/mmr.2021.12102","volume":"23","author":"Liu CP","year":"2021","unstructured":"Liu CP; Zhong M; Sun JX; He J; Gao Y; Qin FX; miR-146a reduces depressive behavior by inhibiting microglial activation. Mol Med Rep  2021,23(6),463","journal-title":"Mol Med Rep"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"826630","DOI":"10.3389\/fcvm.2022.826630","volume":"9","author":"Gissler M.C.","year":"2022","unstructured":"Gissler M.C.; Stachon P.; Wolf D.; Marchini T.; The role of tumor necrosis factor associated factors (TRAFs) in vascular inflammation and atherosclerosis. Front Cardiovasc Med  2022,9,826630","journal-title":"Front Cardiovasc Med"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"13466","DOI":"10.1021\/acs.jmedchem.0c01049","volume":"63","author":"Federico S.","year":"2020","unstructured":"Federico S.; Pozzetti L.; Papa A.; Modulation of the innate immune response by targeting toll-like receptors: A perspective on their agonists and antagonists. J Med Chem  2020,63(22),13466-513","journal-title":"J Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","volume":"118","author":"Feinberg M.W.","year":"2016","unstructured":"Feinberg M.W.; Moore K.J.; MicroRNA regulation of atherosclerosis. Circ Res  2016,118(4),703-720","journal-title":"Circ Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"797046","DOI":"10.3389\/fcvm.2021.797046","volume":"8","author":"Gerhardt T.","year":"2022","unstructured":"Gerhardt T.; Haghikia A.; Stapmanns P.; Leistner D.M.; Immune mechanisms of plaque instability. Front Cardiovasc Med  2022,8,797046","journal-title":"Front Cardiovasc Med"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"6366254","DOI":"10.1155\/2021\/6366254","volume":"2021","author":"Xiao L.","year":"2021","unstructured":"Xiao L.; Gu Y.; Ren G.; miRNA\u2010146a mimic inhibits NOX4\/P38 signalling to ameliorate mouse myocardial ischaemia reperfusion (I\/R) injury. Oxid Med Cell Longev  2021,2021(1),6366254","journal-title":"Oxid Med Cell Longev"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/10715762.2017.1282158","volume":"51","author":"Hendgen-Cotta U.B.","year":"2017","unstructured":"Hendgen-Cotta U.B.; Messiha D.; Esfeld S.; Deenen R.; Rassaf T.; Totzeck M.; Inorganic nitrite modulates miRNA signatures in acute myocardial in vivo ischemia\/reperfusion. Free Radic Res  2017,51(1),91-102","journal-title":"Free Radic Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.ymthe.2021.11.006","volume":"30","author":"Fan C.","year":"2022","unstructured":"Fan C.; Li Y.; Lan T.; Wang W.; Long Y.; Yu S.Y.; Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression. Mol Ther  2022,30(3),1300-1314","journal-title":"Mol Ther"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fncel.2015.00476","volume":"9","author":"Brites D.","year":"2015","unstructured":"Brites D.; Fernandes A.; Neuroinflammation and depression: Microglia activation, extracellular microvesicles and microRNA dysregulation. Front Cell Neurosci  2015,9,476","journal-title":"Front Cell Neurosci"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00401-017-1803-x","volume":"135","author":"Prada I.","year":"2018","unstructured":"Prada I.; Gabrielli M.; Turola E.; Glia-to-neuron transfer of miRNAs via extracellular vesicles: A new mechanism underlying inflammation-induced synaptic alterations. Acta Neuropathol  2018,135(4),529-550","journal-title":"Acta Neuropathol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s43042-024-00543-0","volume":"25","author":"Rajabi S.","year":"2024","unstructured":"Rajabi S.; Sadegi K.; Hajisobhani S.; Kaveh M.; Taghizadeh E.; miR-146a and miR-155 as promising biomarkers for prognosis and diagnosis of multiple sclerosis: Systematic review. Egypt J Med Hum Genet  2024,25(1),73","journal-title":"Egypt J Med Hum Genet"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1094709","DOI":"10.3389\/fneur.2023.1094709","volume":"14","author":"Mao S.","year":"2023","unstructured":"Mao S.; Wu J.; Yan J.; Zhang W.; Zhu F.; Dysregulation of miR-146a: A causative factor in epilepsy pathogenesis, diagnosis, and prognosis. Front Neurol  2023,14,1094709","journal-title":"Front Neurol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"Miller A.H.","year":"2016","unstructured":"Miller A.H.; Raison C.L.; The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nat Rev Immunol  2016,16(1),22-34","journal-title":"Nat Rev Immunol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.tins.2014.12.006","volume":"38","author":"Borsini A.","year":"2015","unstructured":"Borsini A.; Zunszain P.A.; Thuret S.; Pariante C.M.; The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci  2015,38(3),145-57","journal-title":"Trends Neurosci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"115313","DOI":"10.1016\/j.biopha.2023.115313","volume":"166","author":"Valiuliene G.","year":"2023","unstructured":"Valiuliene G.; Valiulis V.; Zentelyte A.; Dapsys K.; Germanavicius A.; Navakauskiene R.; Anti-neuroinflammatory microRNA-146a-5p as a potential biomarker for neuronavigation-guided rTMS therapy success in medication resistant depression disorder. Biomed Pharmacother  2023,166,115313","journal-title":"Biomed Pharmacother"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2021.07.004","volume":"238","author":"Aslani M.","year":"2021","unstructured":"Aslani M.; Mortazavi-Jahromi S.S.; Mirshafiey A.; Efficient roles of miR-146a in cellular and molecular mechanisms of neuroinflammatory disorders: An effectual review in neuroimmunology. Immunol Lett  2021,238,1-20","journal-title":"Immunol Lett"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fneur.2020.00462","volume":"11","author":"Lukiw W.J.","year":"2020","unstructured":"Lukiw W.J.; microRNA-146a signaling in Alzheimer\u2019s Disease (AD) and Prion Disease (PrD). Front Neurol  2020,11,462","journal-title":"Front Neurol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"111413","DOI":"10.1016\/j.mad.2020.111413","volume":"193","author":"Sabbatinelli J.","year":"2021","unstructured":"Sabbatinelli J.; Giuliani A.; Matacchione G.; Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients. Mech Ageing Dev  2021,193,111413","journal-title":"Mech Ageing Dev"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"11192","DOI":"10.1038\/s41598-023-38367-4","volume":"13","author":"Han R.","year":"2023","unstructured":"Han R.; Gao J.; Wang L.; MicroRNA-146a negatively regulates inflammation via the IRAK1\/TRAF6\/NF-\u03baB signaling pathway in dry eye. Sci Rep  2023,13(1),11192","journal-title":"Sci Rep"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41392-022-00886-3","volume":"7","author":"Gong H.","year":"2022","unstructured":"Gong H.; Chen H.; Xiao P.; miR-146a impedes the anti-aging effect of AMPK via NAMPT suppression and NAD+\/SIRT inactivation. Signal Transduct Target Ther  2022,7(1),66","journal-title":"Signal Transduct Target Ther"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"117177","DOI":"10.1016\/j.biopha.2024.117177","volume":"178","author":"Bhol N.K.","year":"2024","unstructured":"Bhol N.K.; Bhanjadeo M.M.; Singh A.K.; The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds. Biomed Pharmacother  2024,178,117177","journal-title":"Biomed Pharmacother"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.molcel.2014.03.030","volume":"54","author":"Chovatiya R.","year":"2014","unstructured":"Chovatiya R.; Medzhitov R.; Stress, inflammation, and defense of homeostasis. Mol Cell  2014,54(2),281-8","journal-title":"Mol Cell"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"e32554","DOI":"10.1097\/MD.0000000000032554","volume":"101","author":"Reist C.","year":"2022","unstructured":"Reist C.; Petiwala I.; Latimer J.; Collaborative mental health care: A narrative review. Medicine (Baltimore)  2022,101(52),e32554","journal-title":"Medicine (Baltimore)"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"10045","DOI":"10.1038\/ncomms10045","volume":"6","author":"Hou Q.","year":"2015","unstructured":"Hou Q.; Ruan H.; Gilbert J.; MicroRNA miR124 is required for the expression of homeostatic synaptic plasticity. Nat Commun  2015,6(1),10045","journal-title":"Nat Commun"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"dev.179556","DOI":"10.1242\/dev.179556","volume":"146","author":"Wohl S.G.","year":"2019","unstructured":"Wohl S.G.; Hooper M.J.; Reh T.A.; MicroRNAs miR-25, let-7 and miR-124 regulate the neurogenic potential of M\u00fcller glia in mice. Development  2019,146(17),dev.179556","journal-title":"Development"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/s42003-024-07089-2","volume":"7","author":"Son G.","year":"2024","unstructured":"Son G.; Na Y.; Kim Y.; miR-124 coordinates metabolic regulators acting at early stages of human neurogenesis. Commun Biol  2024,7(1),1393","journal-title":"Commun Biol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.7150\/thno.53418","volume":"11","author":"Liang C.","year":"2021","unstructured":"Liang C.; Zou T.; Zhang M.; MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer\u2019s disease. Theranostics  2021,11(9),4103-21","journal-title":"Theranostics"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijpsycho.2005.10.012","volume":"59","author":"Rohleder N.","year":"2006","unstructured":"Rohleder N.; Kirschbaum C.; The hypothalamic\u2013pituitary\u2013adrenal (HPA) axis in habitual smokers. Int J Psychophysiol  2006,59(3),236-43","journal-title":"Int J Psychophysiol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/B978-0-444-64123-6.00004-7","volume":"175","author":"Leistner C.","year":"2020","unstructured":"Leistner C.; Menke A.; Hypothalamic\u2013pituitary\u2013adrenal axis and stress. Handb Clin Neurol  2020,175,55-64","journal-title":"Handb Clin Neurol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/ijms19040986","volume":"19","author":"DeMorrow S.","year":"2018","unstructured":"DeMorrow S.; Role of the hypothalamic\u2013pituitary\u2013adrenal axis in health and disease. Int J Mol Sci  2018,19,986","journal-title":"Int J Mol Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","volume":"55","author":"Kim T.","year":"2023","unstructured":"Kim T.; Croce C.M.; MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Exp Mol Med  2023,55(7),1314-21","journal-title":"Exp Mol Med"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41531-024-00791-2","volume":"10","author":"Shaheen N.","year":"2024","unstructured":"Shaheen N.; Shaheen A.; Osama M.; Nashwan A.J.; Bharmauria V.; Flouty O.; MicroRNAs regulation in Parkinson\u2019s disease, and their potential role as diagnostic and therapeutic targets. NPJ Parkinsons Dis  2024,10(1),186","journal-title":"NPJ Parkinsons Dis"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41435-024-00283-6","volume":"25","author":"Artimovi\u010d P.","year":"2024","unstructured":"Artimovi\u010d P.; \u0160pakov\u00e1 I.; Macejkov\u00e1 E.; The ability of microRNAs to regulate the immune response in ischemia\/reperfusion inflammatory pathways. Genes Immun  2024,25(4),277-96","journal-title":"Genes Immun"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.1007\/s12035-023-03446-0","volume":"60","author":"Bhatnagar D.","year":"2023","unstructured":"Bhatnagar D.; Ladhe S.; Kumar D.; Discerning the prospects of miRNAs as a multi-target therapeutic and diagnostic for alzheimer\u2019s disease. Mol Neurobiol  2023,60(10),5954-74","journal-title":"Mol Neurobiol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-016-0053-5","volume":"5","author":"S\u00f8rensen S.S.","year":"2016","unstructured":"S\u00f8rensen S.S.; Nygaard A.B.; Christensen T.; miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer\u2019s disease and other types of dementia: An exploratory study. Transl Neurodegener  2016,5(1),6","journal-title":"Transl Neurodegener"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrg3198","volume":"13","author":"Pritchard C.C.","year":"2012","unstructured":"Pritchard C.C.; Cheng H.H.; Tewari M.; MicroRNA profiling: Approaches and considerations. Nat Rev Genet  2012,13(5),358-69","journal-title":"Nat Rev Genet"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/s43587-024-00683-3","volume":"4","author":"Herzog CMS","year":"2024","unstructured":"Herzog CMS; Goeminne LJE; Poganik JR; Challenges and recommendations for the translation of biomarkers of aging. Nat Aging  2024,4(10),1372-83","journal-title":"Nat Aging"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1038\/s41467-024-47971-5","volume":"15","author":"Karlsson L.","year":"2024","unstructured":"Karlsson L.; Vogel J.; Arvidsson I.; Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases. Nat Commun  2024,15(1),3676","journal-title":"Nat Commun"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1291176","DOI":"10.3389\/fpsyt.2023.1291176","volume":"14","author":"Mancuso E.","year":"2023","unstructured":"Mancuso E.; Sampogna G.; Boiano A.; Biological correlates of treatment resistant depression: A review of peripheral biomarkers. Front Psychiatry  2023,14,1291176","journal-title":"Front Psychiatry"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/s24010037","volume":"24","author":"Das S.","year":"2023","unstructured":"Das S.; Dey M.K.; Devireddy R.; Gartia M.R.; Biomarkers in cancer detection, diagnosis, and prognosis. Sensors  2023,24(1),37","journal-title":"Sensors"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41525-021-00239-z","volume":"6","author":"Rydzewski N.R.","year":"2021","unstructured":"Rydzewski N.R.; Peterson E.; Lang J.M.; Predicting cancer drug TARGETS - TreAtment response generalized elastic-neT signatures. NPJ Genom Med  2021,6(1),76","journal-title":"NPJ Genom Med"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nm.3582","volume":"20","author":"Lopez J.P.","year":"2014","unstructured":"Lopez J.P.; Lim R.; Cruceanu C.; miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat Med  2014,20(7),764-8","journal-title":"Nat Med"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1186\/s12885-022-10242-x","volume":"22","author":"Shang C.","year":"2022","unstructured":"Shang C.; Chen Q.; Zu F.; Ren W.; Integrated analysis identified prognostic microRNAs in breast cancer. BMC Cancer  2022,22(1),1170","journal-title":"BMC Cancer"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"BSR20181139","DOI":"10.1042\/BSR20181139","volume":"38","author":"Wang X.","year":"2018","unstructured":"Wang X.; Wang B.; Zhao J.; Liu C.; Qu X.; Li Y.; MiR-155 is involved in major depression disorder and antidepressant treatment via targeting SIRT1. Biosci Rep  2018,38(6),BSR20181139","journal-title":"Biosci Rep"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12031-018-1231-y","volume":"67","author":"Chua C.E.L.","year":"2019","unstructured":"Chua C.E.L.; Tang B.L.; miR-34a in neurophysiology and neuropathology. J Mol Neurosci  2019,67(2),235-46","journal-title":"J Mol Neurosci"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12974-019-1590-5","volume":"16","author":"Mu\u00f1oz-San Mart\u00edn M.","year":"2019","unstructured":"Mu\u00f1oz-San Mart\u00edn M.; Reverter G.; Robles-Cede\u00f1o R.; Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a\/b in patients with multiple sclerosis and active lesions. J Neuroinflammation  2019,16(1),220","journal-title":"J Neuroinflammation"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"11389","DOI":"10.3390\/ijms231911389","volume":"23","author":"Zhang C.","year":"2022","unstructured":"Zhang C.; Sun C.; Zhao Y.; Overview of MicroRNAs as diagnostic and prognostic biomarkers for high-incidence cancers in 2021. Int J Mol Sci  2022,23(19),11389","journal-title":"Int J Mol Sci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/ijnp\/pyy052","volume":"22","author":"Demyttenaere K.","year":"2019","unstructured":"Demyttenaere K.; Van Duppen Z.; The impact of (the Concept of) treatment-resistant depression: An opinion review. Int J Neuropsychopharmacol  2019,22(2),85-92","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/bph.15753","volume":"179","author":"Borb\u00e9ly \u00c9.","year":"2022","unstructured":"Borb\u00e9ly \u00c9.; Simon M.; Fuchs E.; Wiborg O.; Cz\u00e9h B.; Helyes Z.; Novel drug developmental strategies for treatment\u2010resistant depression. Br J Pharmacol  2022,179(6),1146-86","journal-title":"Br J Pharmacol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"15497","DOI":"10.1038\/ncomms15497","volume":"8","author":"Lopez J.P.","year":"2017","unstructured":"Lopez J.P.; Fiori L.M.; Cruceanu C.; MicroRNAs 146a\/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK\/Wnt-system genes. Nat Commun  2017,8(1),15497","journal-title":"Nat Commun"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.tcb.2014.11.004","volume":"25","author":"Vidigal J.A.","year":"2015","unstructured":"Vidigal J.A.; Ventura A.; The biological functions of miRNAs: Lessons from in vivo studies. Trends Cell Biol  2015,25(3),137-47","journal-title":"Trends Cell Biol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41598-024-52681-5","volume":"14","author":"Sandau U.S.","year":"2024","unstructured":"Sandau U.S.; Wiedrick J.T.; McFarland T.J.; Analysis of the longitudinal stability of human plasma miRNAs and implications for disease biomarkers. Sci Rep  2024,14(1),2148","journal-title":"Sci Rep"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/10408363.2023.2195496","volume":"60","author":"Ma S.","year":"2023","unstructured":"Ma S.; Yu J.; Qin X.; Liu J.; Current status and challenges in establishing reference intervals based on real-world data. Crit Rev Clin Lab Sci  2023,60(6),427-441","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"Rush A.J.","year":"2006","unstructured":"Rush A.J.; Trivedi M.H.; Wisniewski S.R.; Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiatry  2006,163(11),1905-1917","journal-title":"Am J Psychiatry"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"e862-2","DOI":"10.1038\/tp.2016.131","volume":"6","author":"Gururajan A.","year":"2016","unstructured":"Gururajan A.; Naughton M.E.; Scott K.A.; MicroRNAs as biomarkers for major depression: A role for let-7b and let-7c. Transl Psychiatry  2016,6(8),e862-2","journal-title":"Transl Psychiatry"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jad.2018.07.075","volume":"240","author":"Dwivedi Y.","year":"2018","unstructured":"Dwivedi Y.; MicroRNAs in depression and suicide: Recent insights and future perspectives. J Affect Disord  2018,240,146-54","journal-title":"J Affect Disord"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"103569","DOI":"10.1016\/j.ebiom.2021.103569","volume":"71","author":"Shi Y.","year":"2021","unstructured":"Shi Y.; Wang Q.; Song R.; Kong Y.; Zhang Z.; Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers. EBioMedicine  2021,71,103569","journal-title":"EBioMedicine"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jad.2017.11.090","volume":"227","author":"Fang Y.","year":"2018","unstructured":"Fang Y.; Qiu Q.; Zhang S.; Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression. J Affect Disord  2018,227,745-51","journal-title":"J Affect Disord"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.3390\/ijms222111312","volume":"22","author":"\u017burawek D.","year":"2021","unstructured":"\u017burawek D.; Turecki G.; The miRNome of depression. Int J Mol Sci  2021,22(21),11312","journal-title":"Int J Mol Sci"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1987655","DOI":"10.1080\/20008198.2021.1987655","volume":"12","author":"Maffioletti E.","year":"2021","unstructured":"Maffioletti E.; Bocchio-Chiavetto L.; Perusi G.; Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients. Eur J Psychotraumatol  2021,12(1),1987655","journal-title":"Eur J Psychotraumatol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.pnpbp.2016.03.010","volume":"73","author":"Alural B.","year":"2017","unstructured":"Alural B.; Genc S.; Haggarty S.J.; Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future. Prog Neuropsychopharmacol Biol Psychiatry  2017,73,87-103","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s12975-014-0364-8","volume":"5","author":"S\u00f8rensen S.S.","year":"2014","unstructured":"S\u00f8rensen S.S.; Nygaard A.B.; Nielsen M.Y.; Jensen K.; Christensen T.; miRNA expression profiles in cerebrospinal fluid and blood of patients with acute ischemic stroke. Transl Stroke Res  2014,5(6),711-8","journal-title":"Transl Stroke Res"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1179069519832286","DOI":"10.1177\/1179069519832286","volume":"13","author":"Atif H.","year":"2019","unstructured":"Atif H.; Hicks S.D.; A review of MicroRNA biomarkers in traumatic brain injury. J Exp Neurosci  2019,13,1179069519832286","journal-title":"J Exp Neurosci"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41374-018-0143-3","volume":"99","author":"Dave V.P.","year":"2019","unstructured":"Dave V.P.; Ngo T.A.; Pernestig A.K.; MicroRNA amplification and detection technologies: Opportunities and challenges for point of care diagnostics. Lab Invest  2019,99(4),452-69","journal-title":"Lab Invest"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12987-022-00382-4","volume":"19","author":"Liu G.","year":"2022","unstructured":"Liu G.; Ladr\u00f3n-de-Guevara A.; Izhiman Y.; Nedergaard M.; Du T.; Measurements of cerebrospinal fluid production: A review of the limitations and advantages of current methodologies. Fluids Barriers CNS  2022,19(1),101","journal-title":"Fluids Barriers CNS"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41398-024-03075-8","volume":"14","author":"Li Y.B.","year":"2024","unstructured":"Li Y.B.; Fu Q.; Guo M.; Du Y.; Chen Y.; Cheng Y.; MicroRNAs: Pioneering regulators in Alzheimer\u2019s disease pathogenesis, diagnosis, and therapy. Transl Psychiatry  2024,14(1),367","journal-title":"Transl Psychiatry"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/8537296","volume":"2023","author":"Ma Y.M.","year":"2023","unstructured":"Ma Y.M.; Zhao L.; Mechanism and therapeutic prospect of miRNAs in neurodegenerative diseases. Behav Neurol  2023,2023,1-24","journal-title":"Behav Neurol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10059-012-2267-4","volume":"33","author":"Jiang X.","year":"2012","unstructured":"Jiang X.; Xiang G.; Wang Y.; MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-\u03b2 RII. Mol Cells  2012,33(6),545-552","journal-title":"Mol Cells"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"100593","DOI":"10.1016\/j.ctarc.2022.100593","volume":"32","author":"Barwal T.S.","year":"2022","unstructured":"Barwal T.S.; Singh N.; Sharma U.; miR-590\u20135p: A double-edged sword in the oncogenesis process. Cancer Treat Res Commun  2022,32,100593","journal-title":"Cancer Treat Res Commun"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Deng Z.","year":"2024","unstructured":"Deng Z.; Fan T.; Xiao C.; TGF-\u03b2 signaling in health, disease and therapeutics. Signal Transduct Target Ther  2024,9(1),61","journal-title":"Signal Transduct Target Ther"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","volume":"43","author":"Metcalf G.A.D.","year":"2024","unstructured":"Metcalf G.A.D.; MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances. Oncogene  2024,43(28),2135-42","journal-title":"Oncogene"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"12720","DOI":"10.1038\/s41598-017-13031-w","volume":"7","author":"Yoon H.","year":"2017","unstructured":"Yoon H.; Belmonte K.C.; Kasten T.; Bateman R.; Kim J.; Intra- and Inter-individual variability of microRNA levels in human cerebrospinal fluid: Critical implications for biomarker discovery. Sci Rep  2017,7(1),12720","journal-title":"Sci Rep"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00221-022-06524-2","volume":"241","author":"Zhang W.H.","year":"2023","unstructured":"Zhang W.H.; Jiang L.; Li M.; Liu J.; MicroRNA-124: an emerging therapeutic target in central nervous system disorders. Exp Brain Res  2023,241(5),1215-26","journal-title":"Exp Brain Res"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10072-017-2841-9","volume":"38","author":"Li N.","year":"2017","unstructured":"Li N.; Pan X.; Zhang J.; Plasma levels of miR-137 and miR-124 are associated with Parkinson\u2019s disease but not with Parkinson\u2019s disease with depression. Neurol Sci  2017,38(5),761-767","journal-title":"Neurol Sci"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"104515","DOI":"10.1016\/j.phrs.2019.104515","volume":"150","author":"Angelopoulou E.","year":"2019","unstructured":"Angelopoulou E.; Paudel Y.N.; Piperi C.; miR-124 and Parkinson\u2019s disease: A biomarker with therapeutic potential. Pharmacol Res  2019,150,104515","journal-title":"Pharmacol Res"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41398-024-02935-7","volume":"14","author":"Lai G.","year":"2024","unstructured":"Lai G.; Malavolta M.; Marcozzi S.; Late-onset major depressive disorder: Exploring the therapeutic potential of enhancing cerebral brain-derived neurotrophic factor expression through targeted microRNA delivery. Transl Psychiatry  2024,14(1),352","journal-title":"Transl Psychiatry"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"Rupaimoole R.","year":"2017","unstructured":"Rupaimoole R.; Slack F.J.; MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov  2017,16(3),203-222","journal-title":"Nat Rev Drug Discov"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41582-020-0369-8","volume":"16","author":"Brennan G.P.","year":"2020","unstructured":"Brennan G.P.; Henshall D.C.; MicroRNAs as regulators of brain function and targets for treatment of epilepsy. Nat Rev Neurol  2020,16(9),506-519","journal-title":"Nat Rev Neurol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41590-021-00944-y","volume":"22","author":"Rose S.A.","year":"2021","unstructured":"Rose S.A.; Wroblewska A.; Dhainaut M.; A microRNA expression and regulatory nlm activity atlas of the mouse immune system. Nat Immunol  2021,22(7),914-27","journal-title":"Nat Immunol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.stemcr.2023.02.009","volume":"18","author":"Papadimitriou E.","year":"2023","unstructured":"Papadimitriou E.; Koutsoudaki P.N.; Thanou I.; A miR-124-mediated post-transcriptional mechanism controlling the cell fate switch of astrocytes to induced neurons. Stem Cell Reports  2023,18(4),915-35","journal-title":"Stem Cell Reports"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","volume":"438","author":"Kr\u00fctzfeldt J.","year":"2005","unstructured":"Kr\u00fctzfeldt J.; Rajewsky N.; Braich R.; Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature  2005,438(7068),685-9","journal-title":"Nature"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3390\/ijms25052866","volume":"25","author":"Kaurani L.","year":"2024","unstructured":"Kaurani L.; Clinical insights into MicroRNAs in depression: Bridging molecular discoveries and therapeutic potential. Int J Mol Sci  2024,25(5),2866","journal-title":"Int J Mol Sci"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.2147\/NDT.S237116","volume":"15","author":"Xu Y.Y.","year":"2019","unstructured":"Xu Y.Y.; Xia Q.; Xia Q.; Zhang X.; Liang J.; MicroRNA-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with depression. Neuropsychiatr Dis Treat  2019,15,3583-97","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"619","DOI":"10.12688\/f1000research.10300.1","volume":"6","author":"Frodl T.","year":"2017","unstructured":"Frodl T.; Recent advances in predicting responses to antidepressant treatment. F1000 Res  2017,6,619","journal-title":"F1000 Res"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41398-021-01564-8","volume":"11","author":"Fiori L.M.","year":"2021","unstructured":"Fiori L.M.; Orri M.; Aouabed Z.; Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response. Transl Psychiatry  2021,11(1),439","journal-title":"Transl Psychiatry"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"Wu D.","year":"2023","unstructured":"Wu D.; Chen Q.; Chen X.; Han F.; Chen Z.; Wang Y.; The blood\u2013brain barrier: Structure, regulation and drug delivery. Signal Transduct Target Ther  2023,8(1),217","journal-title":"Signal Transduct Target Ther"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41583-024-00829-7","volume":"25","author":"Gao J.","year":"2024","unstructured":"Gao J.; Gunasekar S.; Xia Z.; Gene therapy for CNS disorders: Modalities, delivery and translational challenges. Nat Rev Neurosci  2024,25(8),553-572","journal-title":"Nat Rev Neurosci"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"O\u2019Brien J.","year":"2018","unstructured":"O\u2019Brien J.; Hayder H.; Zayed Y.; Peng C.; Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne)  2018,9,402","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.3390\/cells10113097","volume":"10","author":"Momin M.Y.","year":"2021","unstructured":"Momin M.Y.; Gaddam R.R.; Kravitz M.; Gupta A.; Vikram A.; The challenges and opportunities in the development of microrna therapeutics: a multidisciplinary viewpoint. Cells  2021,10(11),3097","journal-title":"Cells"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.gde.2018.05.002","volume":"52","author":"Munsie M.","year":"2018","unstructured":"Munsie M.; Gyngell C.; Ethical issues in genetic modification and why application matters. Curr Opin Genet Dev  2018,52,7-12","journal-title":"Curr Opin Genet Dev"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.nurpra.2016.08.011","volume":"13","author":"Farmer L.","year":"2017","unstructured":"Farmer L.; Lundy A.; Informed consent: Ethical and legal considerations for advanced practice nurses. J Nurse Pract  2017,13(2),124-30","journal-title":"J Nurse Pract"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41578-023-00581-x","volume":"8","author":"Gawne P.J.","year":"2023","unstructured":"Gawne P.J.; Ferreira M.; Papaluca M.; Grimm J.; Decuzzi P.; New opportunities and old challenges in the clinical translation of nanotheranostics. Nat Rev Mater  2023,8(12),783-98","journal-title":"Nat Rev Mater"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41576-024-00709-x","volume":"25","author":"Yu Z.","year":"2024","unstructured":"Yu Z.; Coorens T.H.H.; Uddin M.M.; Ardlie K.G.; Lennon N.; Natarajan P.; Genetic variation across and within individuals. Nat Rev Genet  2024,25(8),548-62","journal-title":"Nat Rev Genet"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/14604086221104934","volume":"25","author":"Olive P.","year":"2023","unstructured":"Olive P.; Hives L.; Wilson N.; Psychological and psychosocial aspects of major trauma care in the United Kingdom: A scoping review of primary research. Trauma  2023,25(4),338-47","journal-title":"Trauma"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s10462-024-10768-5","volume":"57","author":"Ghebrehiwet I.","year":"2024","unstructured":"Ghebrehiwet I.; Zaki N.; Damseh R.; Mohamad M.S.; Revolutionizing personalized medicine with generative AI: A systematic review. Artif Intell Rev  2024,57(5),128","journal-title":"Artif Intell Rev"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"Malhi G.S.","year":"2018","unstructured":"Malhi G.S.; Mann J.J.; Depression. Lancet  2018,392(10161),2299-312","journal-title":"Lancet"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"210","DOI":"10.9758\/cpn.2017.15.3.210","volume":"15","author":"Singh A.","year":"2017","unstructured":"Singh A.; Kar S.K.; How electroconvulsive therapy works?: Understanding the neurobiological mechanisms. Clin Psychopharmacol Neurosci  2017,15(3),210-221","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.biopsych.2021.05.023","volume":"91","author":"Ousdal O.T.","year":"2022","unstructured":"Ousdal O.T.; Brancati G.E.; Kessler U.; The neurobiological effects of electroconvulsive therapy studied through magnetic resonance: hat have we learned, and where do we go? Biol Psychiatry  2022,91(6),540-9","journal-title":"Biol Psychiatry"},{"key":"ref=171","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03479-9","volume":"2024","author":"Sandhanam K.","year":"2024","unstructured":"Sandhanam K.; Tamilanban T.; Bhattacharjee B.; Manasa K.; Exploring miRNA therapies and gut microbiome\u2013enhanced CAR-T cells: Advancing frontiers in glioblastoma stem cell targeting. Naunyn Schmiedebergs Arch Pharmacol  2024,2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13072-024-00554-6","volume":"17","author":"Prabhakaran R.","year":"2024","unstructured":"Prabhakaran R.; Thamarai R.; Sivasamy S.; Epigenetic frontiers: MiRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy. Epigenetics Chromatin  2024,17(1),31","journal-title":"Epigenetics Chromatin"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/s41467-021-22196-y","volume":"12","author":"Zheng K.","year":"2021","unstructured":"Zheng K.; Hu F.; Zhou Y.; miR-135a-5p mediates memory and synaptic impairments via the Rock2\/Adducin1 signaling pathway in a mouse model of Alzheimer\u2019s disease. Nat Commun  2021,12(1),1903","journal-title":"Nat Commun"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/DDDT.S288859","volume":"15","author":"Zhang S.","year":"2021","unstructured":"Zhang S.; Cheng Z.; Wang Y.; Han T.; The risks of miRNA therapeutics: In a drug target perspective. Drug Des Devel Ther  2021,15,721-33","journal-title":"Drug Des Devel Ther"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/jbm.a.35286","volume":"103","author":"Frasco M.F.","year":"2015","unstructured":"Frasco M.F.; Almeida G.M.; Santos-Silva F.; Pereira M.C.; Coelho M.A.N.; Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells. J Biomed Mater Res A  2015,103(4),1476-84","journal-title":"J Biomed Mater Res A"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"154667","DOI":"10.1016\/j.prp.2023.154667","volume":"248","author":"Ghafouri-Fard S.","year":"2023","unstructured":"Ghafouri-Fard S.; Shoorei H.; Noferesti L.; Nanoparticle-mediated delivery of microRNAs-based therapies for treatment of disorders. Pathol Res Pract  2023,248,154667","journal-title":"Pathol Res Pract"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"106696","DOI":"10.1016\/j.jddst.2025.106696","volume":"106","author":"Rizg W.Y.","year":"2025","unstructured":"Rizg W.Y.; Alghamdi M.A.; Saadany S.E.; Recent advances and future prospects of engineered exosomes as advanced drug and gene delivery systems. J Drug Deliv Sci Technol  2025,106,106696","journal-title":"J Drug Deliv Sci Technol"}],"container-title":["Current Reviews in Clinical and Experimental Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127724328381443250825092900","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/244940\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127724328381443250825092900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:41:05Z","timestamp":1790145665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/244940\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":177,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0127724328381443250825092900","relation":{},"ISSN":["2772-4328"],"issn-type":[{"value":"2772-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-01-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}